FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

416171004: Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3720002019 Glucagon-like peptide 1 receptor agonist en Synonym Active Entire term case insensitive SNOMED CT core module
3720003012 Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3722683016 Incretin mimetic en Synonym Active Entire term case insensitive SNOMED CT core module
3761503014 GLP-1 receptor agonist en Synonym Active Entire term case sensitive SNOMED CT core module

6 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Is a Antidiabetic agent false Inferred relationship Existential restriction modifier
Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Is a Incretin false Inferred relationship Existential restriction modifier
Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Has disposition Hormone false Inferred relationship Existential restriction modifier
Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Has disposition Glucagon-like peptide 1 receptor agonist true Inferred relationship Existential restriction modifier
Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Is a Substance categorized by disposition true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Exenatide Is a True Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Product containing glucagon-like peptide 1 receptor agonist (product) Has active ingredient True Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier 1
Liraglutide Is a True Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Incretin mimetic therapy Direct substance True Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier 2
Albiglutide Is a True Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Lixisenatide Is a True Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Dulaglutide Is a True Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Semaglutide Is a True Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Liraglutide Is a False Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Lixisenatide Is a False Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Albiglutide Is a False Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Dulaglutide Is a False Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Lixisenatide Has active ingredient False Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Lixisenatide 10micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Has active ingredient False Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Lixisenatide 10micrograms/0.2ml solution for injection 3ml pre-filled disposable devices and Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Has active ingredient False Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices Has active ingredient False Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Lyxumia 20micrograms/0.2ml solution for injection 3ml pre-filled pens (Sanofi) Has active ingredient True Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Lyxumia 10micrograms/0.2ml solution for injection 3ml pre-filled pens (Sanofi) Has active ingredient True Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier
Lyxumia 10micrograms/0.2ml solution for injection 3ml pre-filled pen and Lyxumia 20micrograms/0.2ml solution for injection 3ml pre-filled pen (Sanofi) Has active ingredient True Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start